Attorney General Eric T. Schneiderman of New York recently asked GNC, Target, Walgreens, and Walmart to stop sales of certain store brand herbal supplements due to the failure of DNA testing on the detection of

Two woman who developed bladder cancer after taking Actos, lost their trial against the drug’s manufacturer, Takeda Pharmaceuticals. The Las Vegas jury came to its verdict last month and involved Las Vegas resident, Bertha Triana and Henderson resident,

According to the Wall Street Journal, Pfizer plans on selling an over-the-counter version of the cholesterol drug Lipitor. This alarms some because Lipitor has been linked to Type 2 diabetes. The Journal reported that Pfizer has started a

According to Reuters, Pfizer agreed earlier this month to pay $325 million to resolve claims that it defrauded insurers and other healthcare providers by marketing Neurontin for unapproved uses. The news outlet reported that it was the

If you have been following our blog recently, you may be aware that thousands of lawsuits have been filed against Lipitor manufacturer Pfizer over claims that the drug caused people to develop Type 2 diabetes.

As we have reported in past blogs, our experienced drug injury attorneys are actively involved in the Actos MDL litigation. Actos has been linked to bladder cancer in several patients. In fact, there have been several reports

Pfizer recently announced a settlement in principal for $400 million in a class action case that alleges it marketed several medications fraudulently, costing investors money. According to Reuters, the lawsuit claims that between 2006 and 2009, Pfizer marketed

While taking Lipitor, Betty Pauley of Charleston, West Virginia developed Type 2 Diabetes, which has been alleged to be as a direct result of the medication.  Now, instead of trying to manage her cholesterol, she

The U.S. Food and Drug Administration announced a drug safety change for the anti-seizure drug, Potiga (ezogabine) yesterday (10-31-2013).  This new label is the most serious boxed warning the FDA gives. Risks Potiga could cause: retinal abnormalities

The FDA released the following important drug warning regarding the dangers of Eliquis, a drug that is prescribed to prevent blood clots in people who have atrial fibrillations. WARNING: DISCONTINUING ELIQUIS IN PATIENTS WITHOUT ADEQUATE CONTINUOUS ANTICOAGULATION INCREASES RISK